Which hedge funds own WST? WEST PHARMACEUTICAL SVSC INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in WST (WEST PHARMACEUTICAL SVSC INC) in their Q2 2026 13F filings, worth $612.7m in total. The largest holder by portfolio weight is Findlay Park Partners at 2.9% of its book. 2 exited: Ancora Advisors, Viking Global Investors.
11tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold WST? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Findlay Park Partners | Q2 2026 | 2.9% | $214.2m | 596,646 | -3% | reduced |
| Holocene Advisors | Q2 2026 | 0.2% | $98.9m | 275,421 | 35% | added |
| Point72 Asset Management LP | Q2 2026 | 0.2% | $101.7m | 283,396 | 78% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $126.6m | 352,769 | 9% | added |
| Tudor Investment | Q2 2026 | 0.0% | $8.6m | 23,851 | -64% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $30.0m | 83,578 | 5213% | added |
| Woodline Partners | Q2 2026 | 0.0% | $5.6m | 15,498 | 452% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $3.7m | 10,429 | -55% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $11.1m | 30,900 | -85% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $7.6m | 21,290 | 55% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $4.6m | 12,890 | -8% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Ancora Advisors | 0.0% | $17.8k |
| Viking Global Investors | 1.5% | $104.5m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.0% |
How has hedge fund ownership of WST changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $612.7m |
| Q1 2026 | 13 | $514.0m |
| Q4 2025 | 11 | $552.8m |
| Q3 2025 | 8 | $954.8m |
| Q2 2025 | 7 | $489.6m |
| Q1 2025 | 5 | $602.1m |
| Q4 2024 | 8 | $579.7m |
| Q3 2024 | 5 | $627.2m |
| Q2 2024 | 5 | $675.3m |
| Q1 2024 | 11 | $923.3m |
| Q4 2023 | 9 | $628.2m |
| Q3 2023 | 9 | $653.6m |
| Q2 2023 | 7 | $616.8m |
| Q1 2023 | 9 | $626.2m |
| Q4 2022 | 11 | $392.3m |
| Q3 2022 | 9 | $666.2m |
Counts every tracked manager that disclosed WST in that quarter's filing, including managers that have since stopped filing.